Evidence map›Paper›PMID 42745847›Full record

ArticleFrontiers in oncology2026

Myxoid glioneuronal tumor of the septum pellucidum with concurrent dual

Meng Wang, Lingyan Wang, Lili Zhang, Jianwei Zhang, Yonghui Yang, Li Zhang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Meng WangDepartment of Pathology, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.
Lingyan WangDepartment of Pathology, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.
Lili ZhangDepartment of Pathology, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.
Jianwei ZhangDepartment of Pathology, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.
Yonghui YangDepartment of Pathology, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.
Li ZhangDepartment of Pathology, Children's Hospital of Hebei Province, Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, Hebei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxoid glioneuronal tumor (MGNT), a rare neuroepithelial neoplasm newly recognized in the 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (5th edition), is associated with platelet-derived growth factor receptor α (

Indexed as

dysembryoplastic neuroepithelial tumorimmunohistochemistrymyxoid glioneuronal tumornext-generation sequencingseptum pellucidum

Identifiers

PMID42745847
PMCPMC13574602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.